ASO Author Reflections: Tumor Location and TRG in Neoadjuvant Immunotherapy for Esophageal Cancer
- 20 April 2025
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (7) , 4705-4706
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Patients with Upper Third of Esophageal Squamous Cell Carcinoma Have Better Tumor Regression After Neoadjuvant ImmunochemotherapyAnnals of Surgical Oncology, 2025
- Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trialNature Medicine, 2024
- Tumor Regression Grade and Overall Survival following Gastrectomy with Preoperative Therapy for Gastric CancerAnnals of Surgical Oncology, 2023
- Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy – results from the MRC OE02 oesophageal cancer trialHistopathology, 2018